Condition: Idiopathic AngioedemaInterventions: Drug: Omalizumab; Drug: PlacebosSponsors: University of Wisconsin, Madison; Novartis PharmaceuticalsNot yet recruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Diagnosing Respiratory Disease in Children Using Cough Sounds
Conditions: Pneumonia; Bronchiolitis; Asthma; Croup; Upper Respiratory Tract Infection; Lower Respiratory Tract InfectionIntervention: Other: Recording of Infants and Children’s Cough SoundsSponsors: ResApp Health Limited; Massachusetts General Hospital; The Cleveland Clinic; Texas Children’s HospitalNot yet recruiting – verified November 2016 View full post on…
A Study to Evaluate the Relationship Between Use of Albuterol Electronic Multidose Dry Powder Inhaler (eMDPI) and Exacerbations in Patients With Asthma
Condition: AsthmaIntervention: Drug: ABS eMDPISponsor: Teva Branded Pharmaceutical Products, R&D Inc.Not yet recruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Effect of Bronchial Thermoplasty on Moderate Bronchial Asthma in China
Condition: Moderate AsthmaIntervention: Device: Bronchial ThermoplastySponsor: Guangzhou Institute of Respiratory DiseaseRecruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Investigation of Novel Procedure for Methacholine Challenge Testing
Condition: AsthmaInterventions: Device: Wright Nebulizer; Device: Aerogen Solo Nebulizer; Drug: Methacholine ChlorideSponsor: University of SaskatchewanRecruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease
Condition: Sickle Cell DiseaseInterventions: Drug: Azithromycin; Other: PlaceboSponsor: Vanderbilt UniversityRecruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 (Rhizen Pharmaceuticals 3128)
Conditions: Healthy Volunteers; AsthmaInterventions: Drug: RP3128; Drug: PlaceboSponsor: Rhizen Pharmaceuticals SARecruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Expressions of TRPV1 in Airway of Asthmatics
Conditions: Moderate Persistent Asthma; Severe Persistent Asthma; Nodule Solitary Pulmonary; Pulmonary AtelectasisIntervention: Procedure: Bronchial biopsySponsor: Lu Yuan LeeNot yet recruiting – verified October 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Assessing the Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma and Allergic Rhinitis
Conditions: Asthma, Allergic; Rhinitis,Allergic; AllergyInterventions: Drug: Azelastine-Fluticasone Nasal; Drug: PlacebosSponsor: University of DundeeNot yet recruiting – verified October 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Evaluation of Dupilumab in Children With Uncontrolled Asthma (Liberty Asthma Voyage)
Condition: AsthmaInterventions: Drug: dupilumab SAR231893 (REGN668); Drug: Placebo; Drug: Asthma Reliever Therapies; Drug: Asthma Controller Therapies (Incl. prednisone/prednisolone)Sponsors: Sanofi; Regeneron PharmaceuticalsNot yet recruiting – verified October 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days